Protocol No. V59P13E1: A Phase 3, Open-Label,Multi-Center Study to Evaluate the Persistence of Novartis MenACWY Antibody Response in Adolescents who Have Previously received either Novartis MenACWY Conjugate Vaccine or Menactra

Project: Research project

Project Details

StatusFinished
Effective start/end date2/2/09 → 2/1/15

Funding

  • Novartis Vaccines and Diagnostics, Inc ( Award #V59P13E1): $25,004.00